About SHINE:
Headquartered in Janesville, Wisconsin, SHINE Technologies stands as an industry leader in next-generation fusion, deploying innovative fusion and fusion-based technology that seamlessly combines safety, cost-efficiency, and environmental responsibility.
Distinguished by its proprietary medical isotope production processes, SHINE is at the forefront of creating non-carrier-added lutetium-177—a vital component in cutting-edge medical treatments. Anticipating further advancements, the company's forward-looking vision includes the creation of molybdenum-99, a diagnostic tool that plays a pivotal role in medical procedures aimed at detecting heart disease and cancer.
SHINE's commitment to innovation extends beyond the realms of industry and healthcare. Drawing on its fusion-technology expertise, the company has set its sights on addressing one of energy's most complex challenges—nuclear waste recycling. With a comprehensive and visionary approach, SHINE is steadfastly driving advancements across multiple sectors, leaving an indelible mark on the domains of technology, healthcare, and sustainable energy solutions.
About Zeno Power, Inc.
Zeno Power is a leading developer of commercial radioisotope power systems (RPSs). The company, founded in 2018, has offices in Washington, D.C., and Seattle, WA. Zeno is currently executing on contracts with NASA and the DOD, and is on track to deliver its initial RPSs to customers by 2026. Zeno is backed by a world-class portfolio of investors including Tribe Capital, 1517 Fund, AIN Ventures, Balerion Space Ventures, and DCVC. Learn more at zenopower.com.
SHINE Media Contact:
Zeno Media Contact:
Ben Zimmermann
Jonathan Segal
